Last reviewed · How we verify
NCT07155018: MOPs
Micro-Osteoperforations to Accelerate Maxillary Canine Retraction in Class I Malocclusion
NA trial testing Micro-osteoperforations (MOPs) in Malocclusion, Angle Class I in 40 participants. Completed in 30 June 2025.
30 April 2025
Quick facts
| Lead sponsor | Can Tho University of Medicine and Pharmacy |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 January 2025 |
| Primary completion | 30 April 2025 |
| Estimated completion | 30 June 2025 |
| Sites | 1 location across Vietnam |
Drugs / interventions tested
- Micro-osteoperforations (MOPs)
- Conventional Canine Retraction
Conditions studied
- Malocclusion, Angle Class I — all drugs for Malocclusion, Angle Class I →
Sponsor
Can Tho University of Medicine and Pharmacy
Who can join
Adults 16 to 25, any sex, with Malocclusion, Angle Class I. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This single-blinded, split-mouth randomized controlled trial investigates whether micro-osteoperforations (MOPs) can accelerate maxillary canine retraction in orthodontic patients requiring bilateral premolar extraction. The study also evaluates postoperative pain levels using the Visual Analog Scale at 1, 3, and 7 days.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07155018
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Micro-osteoperforations (MOPs)
Trials testing the same drug.
- NCT04968327 — Micro-osteoperforations on the Rate of Canine Retraction · NA · completed
Other recruiting trials for Malocclusion, Angle Class I
Currently open trials in the same condition.
- NCT06823310 — Antibiofilm Activity of Chitosan Nanoparticles Incorporated Into Clear Aligners · NA · active not recruiting
- NCT06743360 — Microanalysis of Changes in 3D Geometry of Orthodontic Mini-implants · active not recruiting
Other Can Tho University of Medicine and Pharmacy trials
Trials by the same sponsor.
- NCT07305077 — One-Minute Preceptor to Improve Bedside Teaching · NA · recruiting
- NCT07260006 — Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Dis · NA · recruiting
- NCT07176871 — Comparing HANT and Conventional NiTi Archwires in Alignment · NA · completed
- NCT06963788 — The Comparative Effects of Using 0.12% Chlorhexidine and Silver Nanoparticles Mouthwashes in Medical Students · Phase 3 · completed
- NCT06944535 — Efficacy of a Modified Lip Repositioning Surgery Technique With Tie Levator Labii Superioris and Without Frenectomy and · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07155018 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Can Tho University of Medicine and Pharmacy
- Last refreshed: 4 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07155018.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing